India sees over 7,800 COVID cases in a day

Surge will continue for the next 10 days, says Health Ministry but urges people not to panic as the variant is not triggering severe infection

April 12, 2023 04:52 pm | Updated April 13, 2023 01:36 am IST - New Delhi

A mock drill under way at Balrampur hospital in Lucknow on April 11, 2023 to check real-time COVID-19 preparedness.

A mock drill under way at Balrampur hospital in Lucknow on April 11, 2023 to check real-time COVID-19 preparedness. | Photo Credit: The Hindu

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12.

India has been registering a steady surge in COVID-19 cases for over two weeks now. The official added that there will be a further rise in cases for the next 8-10 days, after which a decline is expected. “Caution and not panic is the way out,” he said.

Also Read | COVID-19 endemic stage two years away, Yale School of Medicine study suggests

The Health Ministry source said that the current surge is not a “wave” but rather an “endemic cycle” of COVID-19. While Omicron and its sub-lineages continue to be the dominant variant, most of the assigned variants have little or no significant disease severity.

India on April 12 morning reported 7,830 fresh cases in the last 24 hours, the highest in over seven months, according to Health Ministry figures. 

“The XBB.1.16 subvariant of Omicron, which is driving the latest surge, is not a cause of worry and vaccines are effective against it,” said the source. He added that subvariant’s prevalence increased from 21.6% in February to 35.8% in March.

Meanwhile the Health Ministry has said that there is no shortage of the COVID-19 vaccine for those who want to avail of it. “There is enough, and the Central Government is not keen to over-procure and then waste these vaccines. These vaccines are now available at very competitive prices in the market and in the government sector. States are also advised to buy as per need,’’ a Health Ministry official said.

Also read | After high coverage of primary COVID vaccination, precautionary dose uptake stands at 27%

Serum Institute of India CEO Adar Poonawalla tweeted on April 12: “As COVID cases have been rising again with Omicron XBB & its variants, it can be severe for the elderly. I’d suggest for the elderly, mask up & take the Covovax booster which is now available on the COWIN app. It is excellent against all variants & is approved in the US & Europe.”

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.